These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18716850)

  • 1. Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia.
    Dhir M; Montgomery EA; Glöckner SC; Schuebel KE; Hooker CM; Herman JG; Baylin SB; Gearhart SL; Ahuja N
    J Gastrointest Surg; 2008 Oct; 12(10):1745-53. PubMed ID: 18716850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MGMT-B gene promoter hypermethylation in patients with inflammatory bowel disease - a novel finding.
    Mokarram P; Kavousipour S; Sarabi MM; Mehrabani G; Fahmidehkar MA; Shamsdin SA; Alipour A; Naini MA
    Asian Pac J Cancer Prev; 2015; 16(5):1945-52. PubMed ID: 25773792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients.
    Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y
    BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of epigenetic markers to identify colitis associated cancer: Results of module 1 of the ENDCAP-C study.
    Beggs AD; Mehta S; Deeks JJ; James JD; Caldwell GM; Dilworth MP; Stockton JD; Blakeway D; Pestinger V; Vince A; Taniere P; Iqbal T; Magill L; Matthews G; Morton DG;
    EBioMedicine; 2019 Jan; 39():265-271. PubMed ID: 30473377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists.
    Silva AL; Dawson SN; Arends MJ; Guttula K; Hall N; Cameron EA; Huang TH; Brenton JD; Tavaré S; Bienz M; Ibrahim AE
    BMC Cancer; 2014 Nov; 14():891. PubMed ID: 25432628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WNT-pathway activation in IBD-associated colorectal carcinogenesis: potential biomarkers for colonic surveillance.
    Claessen MM; Schipper ME; Oldenburg B; Siersema PD; Offerhaus GJ; Vleggaar FP
    Cell Oncol; 2010 Jan; 32(4):303-10. PubMed ID: 20208143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer.
    Rajamäki K; Taira A; Katainen R; Välimäki N; Kuosmanen A; Plaketti RM; Seppälä TT; Ahtiainen M; Wirta EV; Vartiainen E; Sulo P; Ravantti J; Lehtipuro S; Granberg KJ; Nykter M; Tanskanen T; Ristimäki A; Koskensalo S; Renkonen-Sinisalo L; Lepistö A; Böhm J; Taipale J; Mecklin JP; Aavikko M; Palin K; Aaltonen LA
    Gastroenterology; 2021 Aug; 161(2):592-607. PubMed ID: 33930428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer.
    Galamb O; Kalmár A; Péterfia B; Csabai I; Bodor A; Ribli D; Krenács T; Patai ÁV; Wichmann B; Barták BK; Tóth K; Valcz G; Spisák S; Tulassay Z; Molnár B
    Epigenetics; 2016 Aug; 11(8):588-602. PubMed ID: 27245242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia.
    Chim CS; Pang R; Liang R
    J Clin Pathol; 2008 Nov; 61(11):1214-9. PubMed ID: 18765431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.
    Griffiths EA; Gore SD; Hooker C; McDevitt MA; Karp JE; Smith BD; Mohammad HP; Ye Y; Herman JG; Carraway HE
    Leuk Lymphoma; 2010 Sep; 51(9):1711-9. PubMed ID: 20795789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.
    Chim CS; Pang R; Fung TK; Choi CL; Liang R
    Leukemia; 2007 Dec; 21(12):2527-36. PubMed ID: 17882284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelations of Apoptotic and Cellular Senescence Genes Methylation in Inflammatory Bowel Disease Subtypes and Colorectal Carcinoma in Egyptians Patients.
    Salama RH; Sayed ZEA; Ashmawy AM; Elsewify WA; Ezzat GM; Mahmoud MA; Alsanory AA; Alsanory TA
    Appl Biochem Biotechnol; 2019 Sep; 189(1):330-343. PubMed ID: 30989570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia.
    Román-Gómez J; Cordeu L; Agirre X; Jiménez-Velasco A; San José-Eneriz E; Garate L; Calasanz MJ; Heiniger A; Torres A; Prosper F
    Blood; 2007 Apr; 109(8):3462-9. PubMed ID: 17148581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients.
    Azuara D; Rodriguez-Moranta F; de Oca J; Sanjuan X; Guardiola J; Lobaton T; Wang A; Boadas J; Piqueras M; Monfort D; Galter S; Esteller M; Moreno V; Capellá G
    Inflamm Bowel Dis; 2013 Jan; 19(1):165-73. PubMed ID: 22532293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients.
    Rawson JB; Manno M; Mrkonjic M; Daftary D; Dicks E; Buchanan DD; Younghusband HB; Parfrey PS; Young JP; Pollett A; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B
    Carcinogenesis; 2011 May; 32(5):741-7. PubMed ID: 21304055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer.
    Serafino A; Moroni N; Zonfrillo M; Andreola F; Mercuri L; Nicotera G; Nunziata J; Ricci R; Antinori A; Rasi G; Pierimarchi P
    Oncotarget; 2014 Feb; 5(4):978-92. PubMed ID: 24657851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.
    Azuara D; Aussó S; Rodriguez-Moranta F; Guardiola J; Sanjuan X; Lobaton T; Boadas J; Piqueras M; Monfort D; Guinó E; Moreno V; Capellá G; de Oca J
    Inflamm Bowel Dis; 2018 Nov; 24(12):2555-2564. PubMed ID: 30099509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia.
    Isidro RA; Cruz ML; Isidro AA; Baez A; Arroyo A; González-Marqués WA; González-Keelan C; Torres EA; Appleyard CB
    World J Gastroenterol; 2015 Feb; 21(6):1749-58. PubMed ID: 25684939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix.
    van der Meide WF; Snellenberg S; Meijer CJ; Baalbergen A; Helmerhorst TJ; van der Sluis WB; Snijders PJ; Steenbergen RD
    Gynecol Oncol; 2011 Oct; 123(1):116-22. PubMed ID: 21726894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung.
    Licchesi JD; Westra WH; Hooker CM; Machida EO; Baylin SB; Herman JG
    Carcinogenesis; 2008 May; 29(5):895-904. PubMed ID: 18308762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.